Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells

Rachel A Burga1, Tuongvan Nguyen2, Jane Zulovich2

  • 1Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA; Children's National Health System, Washington, DC, USA.

Cytotherapy
|July 17, 2016
PubMed

Insights

Natural killer (NK) cells offer promising adoptive cell therapy due to their rapid cytotoxic abilities. Genetic modifications enhance NK cell function, overcoming tumor and viral evasion for improved cancer immunotherapy.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial innate immune cells with cytotoxic and cytokine-producing capabilities.
  • Their ability to rapidly lyse target cells without prior sensitization makes them ideal for adoptive cell therapy.
  • Tumors and viruses utilize evasion strategies to escape NK cell-mediated destruction, posing challenges for immunotherapy.

Purpose of the Study:

  • To review recent advancements in genetically modifying NK cells.
  • To explore strategies for enhancing NK cell function for improved immunotherapy.
  • To summarize the application of engineered NK cells in cellular immunotherapy.

Main Methods:

  • Genetic modification techniques to enhance NK cell properties.
  • Introduction of chemokine, high-affinity Fc receptors, and chimeric antigen receptors.
  • Incorporation of suicide genes and forced expression of cytokines like IL-2 and IL-15.

Main Results:

  • Preclinical studies demonstrate enhanced NK cell homing, cytolytic activity, and in vivo persistence.
  • Genetic engineering improves the safety profile of NK cell-based therapies.
  • Engineered NK cells show increased effectiveness against viral infections and malignancies.

Conclusions:

  • Genetic manipulation is a powerful tool to optimize NK cell-based immunotherapies.
  • Overcoming NK cell evasion strategies is key to fully exploiting their therapeutic potential.
  • Advances in NK cell engineering pave the way for novel cellular immunotherapeutic strategies against cancer and viral diseases.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K